| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 98207-13-7 | Lobuprofen HCl |
≥98% | | 询价 |
| 2 | 73857-20-2 | Ranitidine-N-oxide |
≥98% | | 询价 |
| 3 | 149402-51-7 | Photochlor(HTTP) |
≥98% | | 询价 |
| 4 | 955900-27-3 | RK-9123016 |
≥98% | | 询价 |
| 5 | 81996-46-5 | KMUP 1 HCl |
≥98% | | 询价 |
| 6 | 1196732-52-1 | Propargyl-PEG8-amine |
≥98% | | 询价 |
| 7 | | Dapivirine HCl |
≥98% | | 询价 |
| 8 | 677773-32-9 | Etamicastat HCl |
≥98% | | 询价 |
| 9 | 2055105-59-2 | Fluorescein-PEG6-bis-NHS ester |
≥98% | | 询价 |
| 10 | 929634-33-3 | ADAMTS-5 Inhibitor |
≥98% | | 询价 |
| 11 | 40915-84-2 | AT-308 |
≥98% | | 询价 |
| 12 | 71048-99-2 | Bilanafos-sodium |
≥98% | | 询价 |
| 13 | 14009-24-6 | Drotaverine hydrochloride |
≥98% | | 询价 |
| 14 | 586976-24-1 | CTPB |
≥98% | | 询价 |
| 15 | 49697-38-3 | Rimexolone |
≥98% | | 询价 |
| 16 | 298690-60-5 | Ro67-7476 |
≥98% | | 询价 |
| 17 | 220831-12-9 | AU-006 |
≥98% | | 询价 |
| 18 | | Gut restricted-7 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 19 | 927880-90-8 | RAF265 |
| 5mg, 10mg, 25mg, 50mg | 询价 |
| 20 | 90-24-4 | Xanthoxylin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 21 | 627810-06-4 | BMVC |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 22 | 574759-62-9 | VAF347 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 23 | 115810-13-4 | Tubeimoside III |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 24 | 514-85-2 | 9-cis-Retinal |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 25 | 533-87-9 | Aleuritic acid(α-Aleuritic acid) |
≥98% | | 询价 |
| 26 | 519-98-2 | 4-Methylamino antipyrine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 27 | 532-24-1 | Tropinone |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 28 | 332108-65-3 | ABMA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 29 | 2222354-57-4 | HG-12-6 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | 24916-50-5 | Spiramycin I |
≥98% | | 询价 |
| 31 | 42424-50-0 | Polyinosinic-polycytidylic acid sodium |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 32 | 115074-43-6 | Mupirocin calcium hydrate |
≥98% | | 询价 |
| 33 | 547-65-9 | Tulipalin A |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 80-26-2 | α-Terpinyl acetate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | 42206-94-0 | Triacetylresveratrol |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 512-69-6 | Raffinose |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 37 | 138809-10-6 | Pasakbumin B |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 38 | | NIR-Thiol dinitrobenzenesulfonate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 39 | 1392488-07-1 | NIR dye-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 40 | 174391-64-1 | Tsugaric acid A |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 41 | 53625-15-3 | Teucvidin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 42 | 177931-17-8 | Sauchinone |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 43 | 95298-47-8 | Kaji-ichigoside F1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 44 | 2260791-13-5 | OSMI-3 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 45 | 856307-27-2 | 4-Methylamino antipyrine HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | 826-36-8 | Triacetonamine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 47 | 850559-51-2 | BMVC2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 48 | 612048-23-4 | Cysteine protease inhibitor-2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 49 | 6326-06-3 | AH-7614 |
≥98% | | 询价 |
| 50 | 504-84-7 | Erysolin |
≥98% | | 询价 |
| 51 | 329319-07-5 | Licofuranocoumarin |
≥98% | | 询价 |
| 52 | 112636-83-6 | Dicyclanil |
≥98% | | 询价 |
| 53 | 142545-11-7 | Adiaft |
≥98% | | 询价 |
| 54 | 24613-06-7 | Razoxane,(R)- |
≥98% | | 询价 |
| 55 | 139689-19-3 | R(+)-6-Bromo-APB HBr |
≥98% | | 询价 |
| 56 | 186392-65-4 | Ingliforib |
≥98% | | 询价 |
| 57 | 1050480-30-2 | PhiKan-083 |
≥98% | | 询价 |
| 58 | 3575-86-8 | Pyridinium,1,1'-(thiodimethylene)bis(4-formyl-,dichloride,dioxime |
≥98% | | 询价 |
| 59 | 566161-24-8 | BMS-566419 |
≥98% | | 询价 |
| 60 | 24049-18-1 | Alclofenac sodium |
≥98% | | 询价 |
m.cnreagent.com